Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study

J Am Acad Dermatol. 2019 Jul;81(1):273-275. doi: 10.1016/j.jaad.2019.02.031. Epub 2019 Feb 18.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Cohort Studies
  • Drug Substitution / statistics & numerical data*
  • Drug Tolerance
  • Europe
  • Female
  • Humans
  • Internationality
  • Male
  • Middle Aged
  • Obesity / epidemiology*
  • Psoriasis / diagnosis
  • Psoriasis / drug therapy*
  • Retrospective Studies
  • Risk Assessment
  • Sex Factors
  • Time Factors
  • Treatment Failure
  • Treatment Outcome
  • Withholding Treatment / statistics & numerical data*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • secukinumab